Merck Beats Earnings Estimates Through Cost Cutting

Merck Beats Earnings Estimates Through Cost Cutting

Merck & Co., Inc. beat earnings estimates but missed out on revenues because of a negative currency impact and falling revenues from products that lost their patent exclusivity. However, the stock price is up over 3.2% midday today

Merck Beats Earnings Estimates Through Cost Cutting

comments powered by Disqus